Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Hacer Er"'
Autor:
Aysegul Atmaca, Aysegul Ketenci, Ibrahim Sahin, Ihsan Sukru Sengun, Ramazan Ilyas Oner, Hacer Erdem Tilki, Mine Adas, Hatice Soyleli, Tevfik Demir
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
The proposed expert opinion aimed to address the current knowledge on conceptual, clinical, and therapeutic aspects of diabetic peripheral neuropathy (DPN) and to provide a guidance document to assist clinicians for the best practice in DPN care. The
Externí odkaz:
https://doaj.org/article/2fd7aad7ee2e49e293004d555a87047e
Publikováno v:
Mediterranean Journal of Infection, Microbes and Antimicrobials, Vol 13, Iss 1 (2024)
Introduction: Prophylactic administration of fluconazole in very low birth weight newborns (
Externí odkaz:
https://doaj.org/article/43bccf0c54e7482887695560b41dc50b
Publikováno v:
Namık Kemal Tıp Dergisi, Vol 11, Iss 3, Pp 271-275 (2023)
Aim:The mydriatics that used for pupil-dilation in the examination of retinopathy-of-prematurity (ROP) may cause some side-effects in the neurological, gastrointestinal, cardiovascular systems by absorption from the nasal mucosa, cornea, conjunctiva,
Externí odkaz:
https://doaj.org/article/859845fe0f7b45b897dffa8fbffa22e7
Publikováno v:
Journal of Nursology, Vol 26, Iss 2, Pp 99-106 (2023)
Externí odkaz:
https://doaj.org/article/9fd7270ea41240e59c9449fe7b4f9fa8
Autor:
Ömür Cantürk, Şerife Peker, Kenan Kocatürk, Sevilay Yıldız, Bala Başak Öven Ustaalioğlu, Hacer Er, Huriye Öztürk, Selda Duman
Publikováno v:
The Journal of Kartal Training and Research Hospital. 25:203-209
Publikováno v:
JCRPE, Vol 14, Iss 4, Pp 444-452 (2022)
INTRODUCTION: Children born small for gestational age (SGA) are at risk of future obesity and associated comorbidities. Therefore the identification of risk factors and novel biomarkers which are associated with this risk are needed for early detecti
Externí odkaz:
https://doaj.org/article/4dbdf57d1cdb448ba3641006c9be3293
Autor:
Hacer Erdem Tilki
Publikováno v:
Clinical Neurophysiology Practice, Vol 8, Iss , Pp 174-176 (2023)
Externí odkaz:
https://doaj.org/article/19e15f1d91f746d0a88aeaf77615a034
Publikováno v:
International Journal of Medical Biochemistry, Vol 5, Iss 1, Pp 21-27 (2022)
INTRODUCTION: As childhood and adolescence are the periods when cardiovascular risk factors begin to emerge, this study aimed to investigate the serum lipid profiles of the pediatric population in age- and sex-specific partitions. METHODS: The serum
Externí odkaz:
https://doaj.org/article/f58d1047dca142ac898a0e129655d693
Autor:
Hacer Eroglu İÇLİ, Tevfik Berk BİLDACI
Publikováno v:
Archives of Endocrinology and Metabolism, Vol 65, Iss 6, Pp 747-751 (2021)
ABSTRACT Objective: Oral glucose tolerance testing (OGTT) is the current recommended approach for the diagnosis of gestational diabetes mellitus (GDM). Visfatin is a type of novel adipokine of interest that mostly participates in glucose metabolism a
Externí odkaz:
https://doaj.org/article/b94c3d158e4d45cab932ce85906f5776
Autor:
Emel Okulu, Omer Erdeve, Ilknur Kilic, Ozgur Olukman, Sebnem Calkavur, Gokhan Buyukkale, Merih Cetinkaya, Dilek Ulubas, Nihal Demirel, Deniz Hanta, Sabahattin Ertugrul, Nazli Dilay Gultekin, Oguz Tuncer, Nihat Demir, Leyla Bilgin, Nejat Narli, Duran Yildiz, Demet Terek, Ozge Altun Koroglu, Canan Seren, Elif Ozyazici, Ramazan Ozdemir, Hatice Turgut, Fatma Narter, Yasemin Akin, Ahmet Ozyazici, Aysegul Zenciroglu, Huseyin Selim Asker, Zeynel Gokmen, Musa Salihli, Ali Bulbul, Umut Zubarioglu, Begum Atasay, Esin Koc, Turkish Neonatal Society IVIG Study Group, Kurthan Mert, Akan Yaman, Evrim Alyamac Dizdar, Nurdan Uras, Berna Hekimoglu, Ayse Engin Arisoy, Yasemin Senel, Eren Ozek, Hulya Ozdemir, Kadir Tekgunduz, Ibrahim Caner, Sema Tanriverdi, Dilek Sarici, F. Mehmet Kislali, Didem Aliefendioglu, Nilufer Guzoglu, Cumhur Aydemir, Muhittin Celik, Belma Saygili Karagol, Bilge Bayraktar, Suzan Sahin, Ibrahim Murat Hirfanoglu, Betul Acunas, Ferda Ozlu, Ayse Ecevit, Cengiz Arcagok, Neslihan Tekin, Hacer Ergin, Selda Arslan, Asuman Coban
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2022)
IntroductionIntravenous immunoglobulin (IVIG) has been widely used to treat the hemolytic disease of the newborn (HDN). Although it has been shown that IVIG treatment reduces the duration of phototherapy and hospitalization, the use of IVIG in hemoly
Externí odkaz:
https://doaj.org/article/3078603091f1445a90ba776145affc74